Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Auxly Cannabis Group Inc

Healthcare US CBWTF

0.1115USD
0.0005(0.45%)

Last update at 2026-06-03T20:00:00Z

Day Range

0.110.12
LowHigh

52 Week Range

0.040.14
LowHigh

Fundamentals

  • Previous Close 0.11
  • Market Cap139.10M
  • Volume302442
  • P/E Ratio4.95
  • Dividend Yield-%
  • EBITDA42.88M
  • Revenue TTM151.48M
  • Revenue Per Share TTM0.11
  • Gross Profit TTM 86.74M
  • Diluted EPS TTM0.02

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 32.52M -0.35600M -47.74900M -136.55500M -50.24000M
Minority interest - - - 0.00000M 0.01M
Net income 41.85M -16.34800M -44.51100M -130.29300M -33.73900M
Selling general administrative 49.07M 40.73M 40.28M 50.67M 45.72M
Selling and marketing expenses - - - - -
Gross profit 86.74M 59.93M 21.28M 17.92M 19.29M
Reconciled depreciation 11.45M 10.28M 11.21M 21.58M 14.27M
Ebit - - - - -38.93800M
Ebitda - - - -93.40100M -18.29900M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income 32.67M 14.71M -25.94800M -47.56800M -38.93800M
Other operating expenses - - - - -
Interest expense 6.34M 14.46M 25.65M 21.58M 17.67M
Tax provision -9.33800M 15.99M -3.23800M -6.26200M -4.33000M
Interest income 0.13M 0.24M 0.03M 0.34M 1.59M
Net interest income -6.52800M -14.80100M -25.68300M -21.24100M -16.07700M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - - -4.33000M
Total revenue 151.48M 122.33M 101.08M 94.47M 83.83M
Total operating expenses 118.81M 107.61M 127.03M 142.04M 122.77M
Cost of revenue 64.74M 62.40M 79.80M 76.55M 64.54M
Total other income expense net 6.37M -0.26900M 3.88M -68.18400M 4.78M
Discontinued operations - - - - 12.16M
Net income from continuing ops 41.85M -16.34800M -44.51100M -130.29300M -45.91000M
Net income applicable to common shares - - - - -33.73900M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 271.64M 261.53M 261.90M 331.82M 450.42M
Intangible assets 28.21M 29.76M 29.88M 45.47M 74.20M
Earning assets - - - - -
Other current assets - - - 1.40M 6.81M
Total liab 94.06M 145.87M 210.86M 246.13M 242.31M
Total stockholder equity 177.58M 115.66M 51.05M 90.41M 212.52M
Deferred long term liab - - - - -
Other current liab - 3.75M 0.26M - 1.59M
Common stock - - - - 436.51M
Capital stock 549.56M 542.63M 446.56M 444.76M 436.51M
Retained earnings -457.76500M -499.62000M -483.27200M -438.76100M -308.46800M
Other liab - - - - 20.04M
Good will - - - 0.00000M 24.29M
Other assets - - - - 1.58M
Cash 32.28M 18.36M 15.61M 14.64M 14.75M
Cash and equivalents - - - - -
Total current liabilities 45.13M 123.29M 106.97M 92.69M 53.65M
Current deferred revenue - - - - -
Net debt 14.01M 36.33M 127.13M 159.84M 154.06M
Short term debt - - - - -
Short long term debt 6.12M 51.60M 61.35M 54.67M 17.45M
Short long term debt total - - - - -
Other stockholder equity - - - 46.17M 50.27M
Property plant equipment - - - - 226.48M
Total current assets 99.24M 76.61M 67.99M 89.90M 119.97M
Long term investments 0.26M 0.59M 1.09M 1.09M 3.90M
Net tangible assets - - - - 114.03M
Short term investments 0.14M 0.14M 0.14M 0.14M 0.14M
Net receivables 20.80M 21.75M 15.83M 16.63M 31.21M
Long term debt 40.16M 3.09M 81.38M 119.80M 151.36M
Inventory 42.34M 34.00M 31.43M 54.67M 60.01M
Accounts payable 35.80M 44.90M 41.30M 33.05M 30.57M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 172.40M 184.92M 193.92M 241.92M 330.45M
Capital lease obligations 11.37M 13.79M 16.31M 19.12M 21.30M
Long term debt total - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments 0.00000M 0.10M 0.03M 1.18M 9.34M
Change to liabilities - - - 2.87M 0.18M
Total cashflows from investing activities - - - - 17.33M
Net borrowings -10.56200M -14.47600M -8.38800M - -19.55400M
Total cash from financing activities -9.80900M -13.58500M -5.68500M 1.18M 26.40M
Change to operating activities - - - 9.98M -6.25600M
Net income 41.85M -16.34800M -44.51100M -130.29300M -33.73900M
Change in cash 13.92M 2.75M 0.97M -0.11800M -5.90300M
Begin period cash flow 18.36M 15.61M 14.64M 14.75M 20.66M
End period cash flow 32.28M 18.36M 15.61M 14.64M 14.75M
Total cash from operating activities 26.19M 16.78M 8.21M -2.48100M -49.62900M
Issuance of capital stock - 0.00000M 3.13M 7.94M 44.94M
Depreciation 11.45M 10.28M 11.21M 21.58M 14.27M
Other cashflows from investing activities - - - - -0.00300M
Dividends paid - - - - -
Change to inventory -3.24700M 1.57M 12.71M -3.21500M -6.93000M
Change to account receivables 0.95M -5.91800M 0.81M 10.41M -16.65400M
Sale purchase of stock - - - - -
Other cashflows from financing activities - - - - -0.19700M
Change to netincome - - - - -0.50600M
Capital expenditures 2.52M 2.76M 1.60M 9.19M 0.38M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -12.37000M -0.09400M 17.86M 20.04M -29.65700M
Stock based compensation 5.26M 5.04M 1.64M 4.02M 1.43M
Other non cash items -56.05700M -26.42100M -48.22700M -11.42000M 12.03M
Free cash flow 23.68M 14.02M 6.61M -11.67300M -50.00700M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CBWTF
Auxly Cannabis Group Inc		 0.0005 0.45% 0.11 4.95 11.40 0.92 1.08 1.47 4.41
ZTS
Zoetis Inc		 1.20 1.57% 77.59 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR		 0.58 1.91% 31.01 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 - -% 153.91 21.73 14.95 3.16 2.15 3.56 12.82
GALDY
GALDERMA GROUP AG		 -0.79 1.89% 40.92 74.21 41.67 8.64 5.55 9.15 42.22

Reports Covered

Stock Research & News

View All

Profile

Auxly Cannabis Group Inc. operates as a consumer packaged goods company in the cannabis products market in Canada. The company offers cannabis products under various forms, including milled and dried flowers, vape cartridges, infused pre-rolls, pre-rolled, all- in-one vapes, edibles, concentrates, oils, and softgels under the KOLAB PROJECT, Dosecann, BACK FORTY, Foray, and Parcel brand names. It sells its products through supply arrangements with provincial control boards and distributors, medical cannabis sales channels, and retailers, as well as to authorized wholesalers. The company was formerly known as Cannabis Wheaton Income Corp. and changed its name to Auxly Cannabis Group Inc. in June 2018. Auxly Cannabis Group Inc. was incorporated in 1987 and is headquartered in Toronto, Canada.

Auxly Cannabis Group Inc

777 Richmond Street West, Toronto, ON, Canada, M6J 0C2

Key Executives

Name Title Year Born
Mr. Hugo M. Alves CEO & Director 1972
Mr. Michael David Lickver Pres 1986
Mr. Brian Schmitt Chief Financial Officer NA
Mr. Ron Fichter Gen. Counsel & Corp. Sec. NA
Mr. Andrew MacMillan Sr. VP of Commercial NA
Mr. Alan Cooke Sr. VP of Operations NA
Ms. Carla Nawrocki Sr. VP of Corp. Devel. & Strategy NA
Mr. Ian Peter Rapsey Chief Creative Officer 1977
Mr. Kevin Furet Chief Cultivation & Genetics Officer NA
Mr. Vladimir Klacar Sr. VP of Regulatory Affairs & Planning 1989

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions